Farnesyl Protein Transferase (FPT) Inhibitors

Farnesyl Protein Transferase (FPT) inhibitors are a class of compounds that have shown great promise in the field of cancer research and treatment These inhibitors target the enzyme FPT which plays a crucial role in the process of farnesylation a post-translational modification of proteins involved in cell growth and proliferation By blocking FPT activity these inhibitors disrupt the signaling pathways that cancer cells rely on for survival and growth As a result FPT inhibitors have the potential to effectively inhibit tumor growth and metastasis Our company offers a range of high-quality FPT inhibitors that have been extensively tested for their efficacy and safety in pre-clinical and clinical studies With our FPT inhibitors researchers and healthcare professionals can advance their understanding of cancer biology and explore new treatment options for patients

Catalog Number	Chemical Name	CAS #	Price
EI-0193	Andrastin A, Aspergillus fumigatus	174232-42-9	Online Inquiry
EI-0218	Arglabin	84692-91-1	Online Inquiry
EI-1010	FTI-277 hydrochloride	180977-34-8	Online Inquiry
EI-1304	L-778123 hydrochloride	253863-00-2	Online Inquiry
EI-1360	Lonafarnib	193275-84-2	Online Inquiry
EI-1412	Manumycin A	52665-74-4	Online Inquiry
EI-1941	Salirasib	162520-00-5	Online Inquiry
EI-2176	Tipifarnib, Free base	192185-72-1	Online Inquiry

Application

Farnesyl Protein Transferase (FPT) inhibitors are a crucial tool in the fight against cancer These inhibitors work by blocking the activity of the Farnesyl Protein Transferase enzyme which is involved in the transfer of farnesyl groups to proteins that play a role in cell growth and division By inhibiting this enzyme FPT inhibitors can help to prevent the uncontrolled cell growth and proliferation that is characteristic of cancer

In addition to their potential in cancer treatment FPT inhibitors also have applications in other areas of medicine For example they may be used to treat certain genetic diseases that are caused by mutations in proteins involved in farnesylation processes

Furthermore FPT inhibitors hold promise in the field of drug discovery and development By targeting the Farnesyl Protein Transferase enzyme these inhibitors can be used to screen potential drug candidates for their ability to inhibit the enzyme and potentially treat diseases that involve abnormal protein farnesylation

Overall Farnesyl Protein Transferase inhibitors are a versatile tool with applications in cancer treatment genetic disease therapy and drug discovery

Please note that all services are for research use only. Not intended for any clinical use.

Farnesyl Protein Transferase (FPT) Inhibitors